NovaQuest Pharma Opportunities Fund V, L.P.
Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Growth, Late Stage, Pre-IPO, Buyout
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, China, France, Italy, Denmark, Switzerland, Spain, South Korea, Austria, Netherlands, New Zealand, Sweden, Belgium, Norway, Finland
Industries Focus
- Healthcare
- Healthcare Services
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Healthcare Technology
- Consumer Health
- Medical Equipment
- Health Insurance
- Healthcare IT
- Medical Services
- Nutraceuticals
- Animal Health
- Pharmaceutical Services
Investment Size:
30,000,000 to 100,000,000 USD
Investor Details Founded: 2017
NovaQuest Pharma Opportunities Fund V, L.P. is a private equity firm specializing in investments within the pharmaceutical and life sciences sectors. The firm focuses on providing capital solutions to companies in the healthcare industry, aiming to reduce the overall cost of care, address unmet medical needs, and improve patient outcomes. Their investment strategy includes buyouts, growth equity, and recapitalizations, targeting companies in the lower middle market.
The firm has a diverse portfolio that spans various industries within the healthcare sector, including pharmaceuticals, biotechnology, medical devices, and animal health. They have invested in numerous companies across North America and Europe, demonstrating a broad geographical focus. Their investments range from $30 million to $100 million, reflecting a commitment to supporting companies at different stages of development.
NovaQuest Pharma Opportunities Fund V, L.P. is managed by NovaQuest Capital Management, a firm with over $2.5 billion raised across multiple asset classes. The firm has a proven track record of investing in biopharmaceutical assets, with a clinical success rate higher than the industry average. Their approach combines financial investment with operational expertise to drive growth and value creation in their portfolio companies.
Requirements
- Companies in the lower middle market
- Focus on healthcare and pharmaceutical services industries
- Investment sizes ranging from $30 million to $100 million
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Azurity Pharmaceuticals
- Clinical Ink
- Catalyst Clinical Research
- Argenta Limited
- MI:RNA
- Gallant
- Nerviano Medical Sciences Srl
- Hansa Biopharma AB
- Mycovia Pharmaceuticals
- Sebela Pharmaceuticals
- Nevakar
- Cerevel Therapeutics
- Lupin Pharmaceuticals
- Dermavant Sciences
- Lexitas Pharma Services
- TARGAN
- Helparound
- Longwood Fund V
- RxWare
- NostraData Pty Ltd.
Claim this Investor
Are you an official representative of NovaQuest Pharma Opportunities Fund V, L.P.?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim